Affiliated Cancer Hospital of Chongqing University
Affiliated Cancer Hospital of Chongqing University
Chongqing, Chongqing Municipality, China3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML | B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, acute myeloid leukemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-09-03 | NCT04588922 | |
| Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-02-09 | NCT05620017 | |
| A Study of TAVO412 in Patients with Cancer (TAVO412) | cancer, neoplasm | Recruiting | Phase 1 | 2025-01-16 | NCT06761651 |